Therapeutic prostate cancer interventions: a systematic review on pubic arch interference and needle positioning errors

被引：1

作者：

Bloemberg, Jette ^{[1
]}

de Vries, Martijn ^{[1
]}

van Riel, Luigi A. M. J. G. ^{[2
]}

de Reijke, Theo M. ^{[2
]}

Sakes, Aimee ^{[1
]}

Breedveld, Paul ^{[1
]}

van den Dobbelsteen, John J. ^{[1
]}

机构：

[1] Delft Univ Technol, Fac Mech Engn, Dept Biomech Engn, Delft, Netherlands

[2] Univ Amsterdam, Med Ctr, Dept Urol, Amsterdam, Netherlands

来源：

EXPERT REVIEW OF MEDICAL DEVICES | 2024年 / 21卷 / 07期

基金：

芬兰科学院;

关键词：

Brachytherapy; needle positioning error; prostate cancer; pubic arch interference; focal therapy; steerable needle; DOSE-RATE BRACHYTHERAPY; ANDROGEN DEPRIVATION THERAPY; BEAM RADIATION-THERAPY; RATE AFTERLOADING BRACHYTHERAPY; IN-VIVO DOSIMETRY; CATHETER DISPLACEMENT; HDR BRACHYTHERAPY; AMERICAN BRACHYTHERAPY; RADICAL PROSTATECTOMY; IMPLANT DISPLACEMENT;

D O I：

10.1080/17434440.2024.2374761

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

IntroductionThis study focuses on the quantification of and current guidelines on the hazards related to needle positioning in prostate cancer treatment: (1) access restrictions to the prostate gland by the pubic arch, so-called Pubic Arch Interference (PAI) and (2) needle positioning errors. Next, we propose solution strategies to mitigate these hazards.MethodsThe literature search was executed in the Embase, Medline ALL, Web of Science Core Collection*, and Cochrane Central Register of Controlled Trials databases.ResultsThe literature search resulted in 50 included articles. PAI was reported in patients with various prostate volumes. The level of reported PAI varied between 0 and 22.3 mm, depending on the patient's position and the measuring method. Low-Dose-Rate Brachytherapy induced the largest reported misplacement errors, especially in the cranio-caudal direction (up to 10 mm) and the largest displacement errors were reported for High-Dose-Rate Brachytherapy in the cranio-caudal direction (up to 47 mm), generally increasing over time.ConclusionsCurrent clinical guidelines related to prostate volume, needle positioning accuracy, and maximum allowable PAI are ambiguous, and compliance in the clinical setting differs between institutions. Solutions, such as steerable needles, assist in mitigating the hazards and potentially allow the physician to proceed with the procedure.This systematic review was performed in accordance with the PRISMA guidelines. The review was registered at Protocols.io (DOI: dx.doi.org/10.17504/protocols.io.6qpvr89eplmk/v1).ConclusionsCurrent clinical guidelines related to prostate volume, needle positioning accuracy, and maximum allowable PAI are ambiguous, and compliance in the clinical setting differs between institutions. Solutions, such as steerable needles, assist in mitigating the hazards and potentially allow the physician to proceed with the procedure.This systematic review was performed in accordance with the PRISMA guidelines. The review was registered at Protocols.io (DOI: dx.doi.org/10.17504/protocols.io.6qpvr89eplmk/v1).

引用

页码：625 / 641

页数：17

共 103 条

[1] Fractionated high-dose-rate brachytherapy as monotherapy in prostate cancer: Does implant displacement and its correction influence acute and late toxicity? [J].